Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(31 sites)

China

Shengjing Hospital of China Medical University, Shenyang, Liaoning

People's Hospital of Peking University, Beijing

Beijing Children's Hospital, Capital Medical University, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

Children's Hospital of Hunan Province, Changsha